Professor Jeanne Tie from the Walter Eliza Hall Institute for Medical Research (WEHI) is pioneering the use of circulating tumour DNA (ctDNA) as an indicator for risk of cancer recurrence and treatment response in colorectal and pancreatic cancer. To validate the clinical use of ctDNA, Professor Tie leads several multi-site phase II/III Clinical trials across 5 Melbourne hospitals recruiting over 200 patients.
Since 2014, Professor Tie's team have engaged the services of the VCB to ensure co-ordinated and time-sensitive specimen collection, processing and dispatch across multiple hospitals.